New Results
A short ERK5 isoform modulates nucleocytoplasmic shuttling of active ERK5 and associates with poor survival in breast cancer
Mariska Miranda, View ORCID ProfileJodi M. Saunus, Seçkin Akgül, View ORCID ProfileMahdi Moradi Marjaneh, View ORCID ProfileJamie R. Kutasovic, Wei Shi, View ORCID ProfileOishee Chatterjee, View ORCID ProfileFrancesco Casciello, View ORCID ProfileEsdy Rozali, Herlina Y. Handoko, View ORCID ProfileAdrian P. Wiegmans, View ORCID ProfileTianqing Liu, Jason S. Lee, View ORCID ProfileBryan W. Day, View ORCID ProfileStacey L. Edwards, Juliet D. French, View ORCID ProfileAmy E. McCart Reed, View ORCID ProfileGeorgia Chenevix-Trench, Kum Kum Khanna, View ORCID ProfilePeter T. Simpson, View ORCID ProfileSunil R. Lakhani, View ORCID ProfileFares Al-Ejeh
doi: https://doi.org/10.1101/2021.03.23.436061
Mariska Miranda
1Cancer Program, QIMR Berghofer Medical Research Institute, Herston, Australia
Jodi M. Saunus
2UQ Centre for Clinical Research, The University of Queensland, Herston, Australia
Seçkin Akgül
1Cancer Program, QIMR Berghofer Medical Research Institute, Herston, Australia
Mahdi Moradi Marjaneh
1Cancer Program, QIMR Berghofer Medical Research Institute, Herston, Australia
3Currently at Department of Infectious Disease, Imperial College London, London, UK
Jamie R. Kutasovic
2UQ Centre for Clinical Research, The University of Queensland, Herston, Australia
Wei Shi
1Cancer Program, QIMR Berghofer Medical Research Institute, Herston, Australia
Oishee Chatterjee
1Cancer Program, QIMR Berghofer Medical Research Institute, Herston, Australia
4Faculty of Medicine, University of Queensland, St Lucia QLD 4072, Australia
Francesco Casciello
1Cancer Program, QIMR Berghofer Medical Research Institute, Herston, Australia
Esdy Rozali
1Cancer Program, QIMR Berghofer Medical Research Institute, Herston, Australia
Herlina Y. Handoko
1Cancer Program, QIMR Berghofer Medical Research Institute, Herston, Australia
Adrian P. Wiegmans
1Cancer Program, QIMR Berghofer Medical Research Institute, Herston, Australia
Tianqing Liu
1Cancer Program, QIMR Berghofer Medical Research Institute, Herston, Australia
Jason S. Lee
1Cancer Program, QIMR Berghofer Medical Research Institute, Herston, Australia
Bryan W. Day
1Cancer Program, QIMR Berghofer Medical Research Institute, Herston, Australia
Stacey L. Edwards
1Cancer Program, QIMR Berghofer Medical Research Institute, Herston, Australia
4Faculty of Medicine, University of Queensland, St Lucia QLD 4072, Australia
Juliet D. French
1Cancer Program, QIMR Berghofer Medical Research Institute, Herston, Australia
Amy E. McCart Reed
2UQ Centre for Clinical Research, The University of Queensland, Herston, Australia
Georgia Chenevix-Trench
1Cancer Program, QIMR Berghofer Medical Research Institute, Herston, Australia
Kum Kum Khanna
1Cancer Program, QIMR Berghofer Medical Research Institute, Herston, Australia
Peter T. Simpson
2UQ Centre for Clinical Research, The University of Queensland, Herston, Australia
Sunil R. Lakhani
2UQ Centre for Clinical Research, The University of Queensland, Herston, Australia
5Pathology Queensland, The Royal Brisbane & Women’s Hospital, Herston, Australia
Fares Al-Ejeh
1Cancer Program, QIMR Berghofer Medical Research Institute, Herston, Australia
4Faculty of Medicine, University of Queensland, St Lucia QLD 4072, Australia
6Currently at the Qatar Biomedical Research Institute, Doha, Qatar
Posted March 23, 2021.
A short ERK5 isoform modulates nucleocytoplasmic shuttling of active ERK5 and associates with poor survival in breast cancer
Mariska Miranda, Jodi M. Saunus, Seçkin Akgül, Mahdi Moradi Marjaneh, Jamie R. Kutasovic, Wei Shi, Oishee Chatterjee, Francesco Casciello, Esdy Rozali, Herlina Y. Handoko, Adrian P. Wiegmans, Tianqing Liu, Jason S. Lee, Bryan W. Day, Stacey L. Edwards, Juliet D. French, Amy E. McCart Reed, Georgia Chenevix-Trench, Kum Kum Khanna, Peter T. Simpson, Sunil R. Lakhani, Fares Al-Ejeh
bioRxiv 2021.03.23.436061; doi: https://doi.org/10.1101/2021.03.23.436061
A short ERK5 isoform modulates nucleocytoplasmic shuttling of active ERK5 and associates with poor survival in breast cancer
Mariska Miranda, Jodi M. Saunus, Seçkin Akgül, Mahdi Moradi Marjaneh, Jamie R. Kutasovic, Wei Shi, Oishee Chatterjee, Francesco Casciello, Esdy Rozali, Herlina Y. Handoko, Adrian P. Wiegmans, Tianqing Liu, Jason S. Lee, Bryan W. Day, Stacey L. Edwards, Juliet D. French, Amy E. McCart Reed, Georgia Chenevix-Trench, Kum Kum Khanna, Peter T. Simpson, Sunil R. Lakhani, Fares Al-Ejeh
bioRxiv 2021.03.23.436061; doi: https://doi.org/10.1101/2021.03.23.436061
Subject Area
Subject Areas
- Biochemistry (11718)
- Bioengineering (8724)
- Bioinformatics (29132)
- Biophysics (14936)
- Cancer Biology (12051)
- Cell Biology (17360)
- Clinical Trials (138)
- Developmental Biology (9406)
- Ecology (14146)
- Epidemiology (2067)
- Evolutionary Biology (18269)
- Genetics (12223)
- Genomics (16768)
- Immunology (11844)
- Microbiology (28016)
- Molecular Biology (11560)
- Neuroscience (60822)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3231)
- Physiology (4940)
- Plant Biology (10401)
- Synthetic Biology (2878)
- Systems Biology (7333)
- Zoology (1642)